UKA does not agree with the use of testosterone suppression for transgender women:
a. Scientific evidence, as detailed in the SCEG Guidance is that transgender women retain a testosterone/puberty advantage over biological females regardless of the reduction of post puberty testosterone levels.
b. There is currently no scientifically robust, independent research showing that all male performance advantage is eliminated following testosterone suppression.
c. UKA has seen no evidence that it is safe for transgender women to reduce their hormonal levels by testosterone suppression. Further, there is insufficient research to understand the effects on transgender women if such testosterone suppression is carried out suddenly.
d. The category of “women’s athletics” arose as a way of enabling the inclusion of women in athletics. Women who wished to compete in athletics could not do so fairly with men, because of the physical advantages men enjoy due to their (male) biological sex. Therefore, the decision was made to create a separate, sex-based category in which people of the female sex could fairly compete against one another. The category of women’s sport arose not as a response to women’s social role or personal gender identity, but to ensure fair competition amongst female athletes by eliminating the advantages enjoyed by male athletes on account of their sex.
- In recognition of the available scientific evidence, UKA believes that efforts should be made to:
a. fairly and safely include transgender women in an “open” category, which would replace the current male category and be open to athletes of all sexes; and
b. reserve the women’s category for competitors who were female at birth, so that they can continue to compete fairly.